PEAK6 Investments’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-133,900
Closed -$5.13M 4055
2024
Q1
$5.13M Buy
133,900
+39,100
+41% +$1.89M 0.01% 822
2023
Q4
$6.37M Buy
94,800
+55,200
+139% +$3.85M 0.02% 680
2023
Q3
$2.96M Buy
39,600
+37,300
+1,622% +$3.31M 0.01% 1059
2023
Q2
$212K Sell
2,300
-2,700
-54% -$240K ﹤0.01% 2844
2023
Q1
$518K Sell
5,000
-14,700
-75% -$1.63M ﹤0.01% 2367
2022
Q4
$2.27M Buy
19,700
+3,800
+24% +$442K 0.01% 1237
2022
Q3
$1.72M Buy
15,900
+13,600
+591% +$1.95M 0.01% 1698
2022
Q2
$212K Buy
2,300
+800
+53% +$143K ﹤0.01% 2845
2022
Q1
$256K Buy
+1,500
New +$283K ﹤0.01% 3691
2021
Q4
Sell
-11,100
Closed -$2.14M 5526
2021
Q3
$2.14M Sell
11,100
-17,100
-61% -$4.2M ﹤0.01% 1882
2021
Q2
$7.98M Sell
28,200
-5,900
-17% -$1.6M 0.02% 802
2021
Q1
$7.22M Buy
34,100
+26,900
+374% +$6.44M 0.02% 803
2020
Q4
$1.41M Buy
+7,200
New +$1.27M ﹤0.01% 2159
2020
Q3
Sell
-10,000
Closed -$1.39M 4682
2020
Q2
$1.39M Buy
+10,000
New +$918K ﹤0.01% 1812
2019
Q4
Sell
-40,000
Closed -$4.14M 3774
2019
Q3
$4.14M Buy
40,000
+36,700
+1,112% +$3.94M 0.03% 792
2019
Q2
$423K Buy
+3,300
New +$458K ﹤0.01% 2391

Other funds holding MED

PEAK6 Investments's MED Position: Q2 2024 in Review

PEAK6 Investments sold out of Medifast (MED) in Q2 2024, closing a stake of 82,437 shares — an estimated $3.16M sold.

PEAK6 Investments first reported a position in MED in Q1 2019 and held it in 12 quarters. The position peaked at $3.16M in Q1 2024. 158 funds tracked by Wall St. Rank hold MED as of Q2 2024.

  • PEAK6 Investments reported no remaining Medifast position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 82,437 Medifast shares in Q2 2024, an estimated $3.16M.
  • PEAK6 Investments first reported a position in Medifast in Q1 2019 and held it in 12 quarters.
  • PEAK6 Investments's Medifast position peaked at $3.16M in Q1 2024.
  • 158 funds tracked by Wall St. Rank held Medifast as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.